Edwin Trevathan Archives
Trevathan announces plan to step down from role as VIGH director
Oct. 11, 2021—Edwin Trevathan, MD, MPH, has announced plans to step down from his role as director of the Vanderbilt Institute for Global Health.
NIH grant bolsters childhood status epilepticus and epilepsy research in Nigeria
Mar. 2, 2021—The Vanderbilt Institute for Global Health (VIGH) has received a new research grant from the National Institute of Neurological Disorders and Stroke and Fogarty International Center of the NIH to establish a large childhood status epilepticus (SE) cohort in northern Nigeria with key partners Aminu Kano Teaching Hospital (AKTH) and Bayero University, and with the Sydney Brenner Institute for Molecular Bioscience at the University of the Witwatersrand (Wits) in South Africa.
VIGH’s Trevathan appointed to NINDS Advisory Council
Jan. 23, 2020—Edwin Trevathan, MD, MPH, director of the Vanderbilt Institute for Global Health, has been appointed to the Advisory Council for the National Institute for Neurological Diseases and Stroke (NINDS) of the National Institutes of Health.
VIGH study seeks to expand epilepsy care efforts in Africa
Oct. 10, 2019—The Vanderbilt Institute for Global Health (VIGH), with Aminu Kano Teaching Hospital (AKTH), will conduct a clinical trial in three cities in northern Nigeria to determine the efficacy of shifting childhood epilepsy care to epilepsy-trained community health extension workers.
Trevathan named director for the Vanderbilt Institute for Global Health
Nov. 20, 2017—Edwin Trevathan, MD, MPH, a pediatric neurologist and epidemiologist who has previously held prominent university leadership positions at Washington University in St. Louis (director of Pediatric Neurology), St. Louis University (dean, School of Public Health) and Baylor University (Provost and Executive Vice President) as well as at the U.S. Centers for Disease Control and Prevention (CDC), has been appointed director of the Vanderbilt Institute for Global Health (VIGH), effective Jan. 1, 2018.